跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 77,042 条关于
“Diffuse large B cell lymphoma”
全部
77,042
临床试验
50,493
药物
6,480
机构
3,260
资讯
16,809
去年
Imugene Reports 75% Response Rate in Diffuse Large B-Cell Lymphoma Trial
3年前
GSK's Belantamab Mafodotin Expands Development Portfolio to Target Diffuse Large B-Cell Lymphoma
去年
Biomarker Testing Revolutionizes Treatment Approaches in Diffuse Large B-Cell Lymphoma
去年
Novel Combination Therapy Shows Promise in Diffuse Large B-Cell Lymphoma Treatment
去年
Targeting CD30 in Diffuse Large B-Cell Lymphoma: Where Does It Fit in?
2年前
Polatuzumab Offers New Hope for Diffuse Large B-Cell Lymphoma Treatment in India
2年前
Brentuximab Vedotin Triplet Shows Superior Outcomes in Relapsed/Refractory DLBCL
2个月前
Multi-Omics Study Reveals Proteogenomic Signature of High-Risk Diffuse Large B-Cell Lymphoma
4个月前
UC Davis Tests Novel Immunotherapy-Chemotherapy Sequence for High-Risk Diffuse Large B-Cell Lymphoma
4年前
Phase 1/Dose Expansion Trial of Brentuximab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
第 1 页，共 1681 页
上一页
下一页
